Neuroprotective effects of the allosteric agonist of metabotropic glutamate receptor 7 AMN082 on oxygen-glucose deprivation- and kainate-induced neuronal cell death

被引:23
|
作者
Domin, Helena [1 ]
Jantas, Danuta [2 ]
Smialowska, Maria [1 ]
机构
[1] Polish Acad Sci, Inst Pharmacol, Dept Neurobiol, PL-31343 Krakow, Poland
[2] Polish Acad Sci, Inst Pharmacol, Dept Expt Neuroendocrinol, PL-31343 Krakow, Poland
关键词
mGluR7; MMPIP; Ischemia; Neuroprotection; Calpains; Caspase-3; FOCAL CEREBRAL-ISCHEMIA; EXCITATORY AMINO-ACIDS; CALPAIN-I; NEUROTRANSMITTER RELEASE; MEDIATED EXCITOTOXICITY; ANIMAL-MODELS; ACTIVATION; ANTAGONIST; PROTEIN; DAMAGE;
D O I
10.1016/j.neuint.2014.12.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although numerous studies demonstrated a neuroprotective potency of unspecific group III mGluR agofists in in vitro and in vivo models of excitotoxicity, little is known about the protective role of group III mGlu receptor activation against neuronal cell injury evoked by ischemic conditions. The aim of the present study was to assess neuroprotective potential of the allosteric agonist of mGlu7 receptor, N,N'-Bis(diphenylmethyl)-1,2-ethanediamine dihydrochloride (AMN082) against oxygen-glucose deprivation (OGD)- and kainate (KA)-evoked neuronal cell damage in primary neuronal cultures, with special focus on its efficacy after delayed application. We demonstrated that in cortical neuronal cultures exposed to a 180 min OGD, AMN082 (0.01-1 mu M) in a concentration- and time-dependent way attenuated the OGD-induced changes in the LDH release and MIT reduction assays. AMN082 (0.5 and 1 mu M) produced also neuroprotective effects against KA-evoked neurotoxicity both in cortical and hippocampal cultures. Of particular importance was the finding that AMN082 attenuated excitotoxic neuronal injury after delayed application (30 min after OGD, or 30 min-1 h after KA). In both models of neurotoxicity, namely OGD- and KA-induced injury, the neuroprotective effects of AMN082 (1 gM) were reversed by the selective mGlu7 antagonist, 6-(4-Methoxyphenyl)-5-methyl-3-(4-pyridinyl)-isoxazolo[4,5-c]pyridin-4(5H)-one hydrochloride (MMPIP, 1 mu M), suggesting the mGlu7-dependent mechanism of neuroprotective effects of AMN082. Next, we showed that AMN082 (0.5 and 1 mu M) attenuated the OGD-induced increase in the number of necrotic nuclei as well inhibited the OGD-evoked calpain activation, suggesting the participation of these processes in the mechanism of AMN082-mediated protection. Additionally, we showed that protection evoked by AMN082 (1 mu M) in KA model was connected with the inhibition of toxin-induced caspase-3 activity, and this effect was abolished by the mGlu7 receptor antagonist, The obtained results indicated that the activation of mGlu7 receptors may be a promising target for neuroprotection against ischemic and excitotoxic insults. (C) 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:110 / 123
页数:14
相关论文
共 45 条
  • [1] The Metabotropic Glutamate Receptor 7 Allosteric Modulator AMN082: A Monoaminergic Agent in Disguise?
    Rizzo, Stacey J. Sukoff
    Leonard, Sarah K.
    Gilbert, Adam
    Dollings, Paul
    Smith, Deborah L.
    Zhang, Mei-Yi
    Di, Li
    Platt, Brian J.
    Neal, Sarah
    Dwyer, Jason M.
    Bender, Corey N.
    Zhang, Jean
    Lock, Tim
    Kowal, Dianne
    Kramer, Angela
    Randall, Andrew
    Huselton, Christine
    Vishwanathan, Karthick
    Tse, Susanna Y.
    Butera, John
    Ring, Robert H.
    Rosenzweig-Lipson, Sharon
    Hughes, Zoe A.
    Dunlop, John
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 338 (01): : 345 - 352
  • [2] The metabotropic glutamate receptor 7 (mGluR7) allosteric agonist AMN082 modulates nucleus accumbens GABA and glutamate, but not dopamine, in rats
    Li, Xia
    Gardner, Eliot L.
    Xi, Zheng-Xiong
    NEUROPHARMACOLOGY, 2008, 54 (03) : 542 - 551
  • [3] The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 inhibits inflammatory pain-induced and incision-induced hypersensitivity in rat
    Dolan, Sharron
    Gunn, Mark D.
    Biddlestone, Laura
    Nolan, Andrea M.
    BEHAVIOURAL PHARMACOLOGY, 2009, 20 (07): : 596 - 604
  • [4] AMN082, a metabotropic glutamate receptor 7 allosteric agonist, attenuates locomotor sensitization and cross-sensitization induced by cocaine and morphine in mice
    Jenda, M.
    Gawel, K.
    Marszalek, M.
    Komsta, L.
    Kotlinska, J. H.
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2015, 57 : 166 - 175
  • [5] Metabotropic glutamate receptor 7 (mGluR7) allosteric agonist, AMN082 attenuates the acquisition and expression of cocaine-induced behavioral sensitization in mice
    Małgorzata Jenda
    Kinga Gaweł
    Jolanta H. Kotlińska
    Pharmacological Reports, 2013, 65 (Suppl 1) : 50 - 50
  • [6] The selective metabotropic glutamate receptor 7 allosteric agonist AMN082 prevents reinstatement of extinguished ethanol-induced conditioned place preference in mice
    Bahi, Amine
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2012, 101 (02) : 193 - 200
  • [7] Metabotropic glutamate 7 receptor agonist AMN082 inhibits glutamate release in rat cerebral cortex nerve terminal
    Wang, Che Chuan
    Kuo, Jinn Rung
    Huang, Shu Kuei
    Wang, Su Jane
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2018, 823 : 11 - 18
  • [8] Neuroprotective action of group I metabotropic glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death
    Kalda, A
    Kaasik, A
    Vassiljev, V
    Pokk, P
    Zharkovsky, A
    BRAIN RESEARCH, 2000, 853 (02) : 370 - 373
  • [9] Sublethal oxygen-glucose deprivation alters hippocampal neuronal AMPA receptor expression and vulnerability to kainate-induced death
    Ying, HS
    Weishaupt, JH
    Grabb, M
    Canzoniero, LMT
    Sensi, SL
    Sheline, CT
    Monyer, H
    Choi, DW
    JOURNAL OF NEUROSCIENCE, 1997, 17 (24): : 9536 - 9544
  • [10] Activation of Metabotropic Glutamate Receptor 7 by AMN082 Attenuates the Rewarding Effects of Cocaine and Nicotine in Rats
    Li, Xia
    Stoker, Astrid
    Xi, Zheng-Xiong
    Gardner, Eliot
    Markou, Athina
    BIOLOGICAL PSYCHIATRY, 2013, 73 (09) : 324S - 324S